{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:20:48Z","timestamp":1761844848657},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12876-018-0758-2","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T07:48:47Z","timestamp":1519199327000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma"],"prefix":"10.1186","volume":"18","author":[{"given":"Paulo C.","family":"Soares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana S.","family":"Abdelhay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Claudio S.","family":"Thuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Moreira","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Demachki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gessica Val\u00e9ria Rocha","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo P.","family":"Assump\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia Martins","family":"Lamar\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Felipe","family":"Ribeiro Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rommel Mario Rodr\u00edguez","family":"Burbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,21]]},"reference":[{"key":"758_CR1","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.hoc.2012.08.011","volume":"26","author":"R Glynne-Jones","year":"2012","unstructured":"Glynne-Jones R, Renehan A. Current treatment of anal squamous cell carcinoma. Hematol Oncol Clin North Am. 2012;26:1315\u201350.","journal-title":"Hematol Oncol Clin North Am"},{"key":"758_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/bjc.2016.398","volume":"116","author":"CM Jones","year":"2017","unstructured":"Jones CM, Goh V, Sebag-Montefiore D, Gilbert DC. Biomarkers in anal cancer: from biological understanding to stratified treatment. Br J Cancer. 2017;116:156\u201362.","journal-title":"Br J Cancer"},{"key":"758_CR3","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/sj.bjc.6605984","volume":"103","author":"T Lampejo","year":"2010","unstructured":"Lampejo T, Kavanagh D, Clark J, Goldin R, Osborn M, Ziprin P, Cleator S. Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review. Br J Cancer. 2010;103:1858\u201369.","journal-title":"Br J Cancer"},{"key":"758_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-T\u00e2n PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24\u201335.","journal-title":"N Engl J Med"},{"key":"758_CR5","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1200\/JCO.2010.29.2904","volume":"28","author":"D Rischin","year":"2010","unstructured":"Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O\u2019Sullivan B, Kenny LM, McArthur GA. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 2010;28:4142\u20138.","journal-title":"J Clin Oncol"},{"key":"758_CR6","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/ijc.25825","volume":"129","author":"HY Yhim","year":"2011","unstructured":"Yhim HY, Lee NR, Song EK, Kwak JY, Lee ST, Kim JH, Kim JS, Park HS, Chung IJ, Shim HJ, Hwang JE, Kim HR, Nam TK, Park MR, Shim H, Park HS, Kim HS, Yim CY. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy. Int J Cancer. 2011;129:1752\u201360.","journal-title":"Int J Cancer"},{"key":"758_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.radonc.2013.08.002","volume":"109","author":"DC Gilbert","year":"2013","unstructured":"Gilbert DC, Williams A, Allan K, Stokoe J, Jackson T, Linsdall S, Bailey CM, Summers J. p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy. Radiother Oncol. 2013;109:146\u201351.","journal-title":"Radiother Oncol"},{"key":"758_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.radonc.2014.11.013","volume":"113","author":"SA Koerber","year":"2014","unstructured":"Koerber SA, Schoneweg C, Slynko A, Krug D, Haefner MF, Herfarth K, Debus J, Sterzing F, von Knebel Doeberitz M, Prigge ES, Reuschenbach M. Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer. Radiother Oncol. 2014;113:331\u20136.","journal-title":"Radiother Oncol"},{"key":"758_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.ijrobp.2015.08.004","volume":"93","author":"S Mai","year":"2015","unstructured":"Mai S, Welzel G, Ottstadt M, Lohr F, Severa S, Prigge ES, Wentzensen N, Trunk MJ, Wenz F, von Knebel-Doeberitz M, Reuschenbach M. Prognostic relevance of HPV infection and p16 overexpression in squamous cell anal cancer. Int J Radiat Oncol Biol Phys. 2015;93:819\u201327.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"758_CR10","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/bjc.2015.20","volume":"112","author":"D Meulendijks","year":"2015","unstructured":"Meulendijks D, Tomasoa NB, Dewit L, Smits PH, Bakker R, van Velthuysen ML, Rosenberg EH, Beijnen JH, Schellens JH, Cats A. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53. Br J Cancer. 2015;112:1358\u201366.","journal-title":"Br J Cancer"},{"key":"758_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ijc.28979","volume":"136","author":"F R\u00f6del","year":"2015","unstructured":"R\u00f6del F, Wieland U, Fraunholz I, Kitz J, Rave-Fr\u00e4nk M, Wolff HA, Weiss C, Wirtz R, Balermpas P, Fokas E, R\u00f6del C. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy. Int J Cancer. 2015;136:278\u201388.","journal-title":"Int J Cancer"},{"key":"758_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1470-2045(17)30071-2","volume":"18","author":"R Glynne-Jones","year":"2017","unstructured":"Glynne-Jones R, Sebag-Montefiore D, Meadows HM, Cunningham D, Begum R, Adab F, Benstead K, Harte RJ, Stewart J, Beare S, Hackshaw A, Kadalayil L. ACT II study group. Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of theanus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial. Lancet Oncol. 2017;18:347\u201356.","journal-title":"Lancet Oncol."},{"key":"758_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00384-010-1080-9","volume":"26","author":"L Vercellino","year":"2011","unstructured":"Vercellino L, Montravers F, de Parades V, Huchet V, Kerrou K, Bauer P, Touboul E, Talbot JN. Impact of FDG PET\/CT in the staging and the follow-up of anal carcinoma. Int J Color Dis. 2011;26:201\u201310.","journal-title":"Int J Color Dis"},{"key":"758_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.6004\/jnccn.2012.0046","volume":"10","author":"AB Benson 3rd","year":"2012","unstructured":"Benson AB 3rd, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fakih MG, Fleshman JW Jr, Fuchs CS, Grem JL, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett C, Freedman-Cass DA. National Comprehensive Cancer Network.. Anal carcinoma, version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2012;10:449\u201354.","journal-title":"J Natl Compr Cancer Netw"},{"key":"758_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ijrobp.2007.09.005","volume":"71","author":"JK Schwarz","year":"2008","unstructured":"Schwarz JK, Siegel BA, Dehdashti F, Myerson RJ, Fleshman JW, Grigsby PW. Tumor response and survival predicted by post-therapy FDG-PET\/CT in anal cancer. Int J Radiat Oncol Biol Phys. 2008;71:180\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"758_CR16","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00261-012-9958-3","volume":"38","author":"SS Saboo","year":"2013","unstructured":"Saboo SS, Zukotynski K, Shinagare AB, Krajewski KM, Ramaiya N. Anal carcinoma: FDG PET\/CT in staging, response evaluation, and follow-up. Abdom Imaging. 2013;38:728\u201335.","journal-title":"Abdom Imaging"},{"key":"758_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/BF02586980","volume":"17","author":"ND Nigro","year":"1974","unstructured":"Nigro ND, Vaitkevicius VK, Considine B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon rectum. 1974;17:354\u20136.","journal-title":"Dis Colon rectum"},{"key":"758_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1600-0463.2012.02918.x","volume":"120","author":"MH Faria","year":"2012","unstructured":"Faria MH, Neves Filho EH, Alves MK, Burbano RM, de Moraes Filho MO, Rabenhorst SH. TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression. APMIS Acta Pathol Microbiol Immunol Scand. 2012;120:882\u20139.","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand"},{"key":"758_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF00500631","volume":"89","author":"AH Hopman","year":"1988","unstructured":"Hopman AH, Ramaekers FC, Raap AK, Beck JL, Devilee P, van der Ploeg M, Vooijs GP. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry. 1988;89:307\u201316.","journal-title":"Histochemistry"},{"key":"758_CR20","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3748\/wjg.v18.i13.1531","volume":"18","author":"MF Leal","year":"2012","unstructured":"Leal MF, Calcagno DQ, Demachki S, Assump\u00e7\u00e3o PP, Chammas R, Burbano RR, Smith Mde A. Clinical implication of 14-3-3 epsilon expression in gastric cancer. World J Gastroenterol. 2012;18:1531\u20137.","journal-title":"World J Gastroenterol"},{"key":"758_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.12816\/0006000","volume":"6","author":"SA Salati","year":"2012","unstructured":"Salati SA, Al KA. Anal cancer - a review. Int J Health Sci. 2012;6:206\u201330.","journal-title":"Int J Health Sci"},{"key":"758_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.ijrobp.2009.08.055","volume":"78","author":"V Goh","year":"2010","unstructured":"Goh V, Gollub FK, Liaw J, Wellsted D, Przybytniak I, Padhani AR, Glynne-Jones R. Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can mri predict for eventual clinical outcome? Int J Radiat Oncol Biol Phys. 2010;78:715\u201321.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"758_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"J RD","year":"2013","unstructured":"RD J, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial. Lancet Oncol. 2013;14:516\u201324.","journal-title":"Lancet Oncol"},{"key":"758_CR24","first-page":"161","volume":"20","author":"A Cardesa","year":"2011","unstructured":"Cardesa A, Nadal A. Carcinoma of the head and neck in the HPV era. Acta Derm Venerol Alp Pannonica Adriat. 2011;20:161\u201373.","journal-title":"Acta Derm Venerol Alp Pannonica Adriat"},{"key":"758_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1071\/SH11167","volume":"9","author":"F Coutl\u00e9e","year":"2012","unstructured":"Coutl\u00e9e F, de Pokomandy A, Franco EL. Epidemiology, natural history and risk factors for anal intraepithelial neoplasia. Sex Health. 2012;9:547\u201355.","journal-title":"Sex Health"},{"key":"758_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1071\/SH12010","volume":"9","author":"UM Szmulowicz","year":"2012","unstructured":"Szmulowicz UM, Wu JS. Squamous cell carcinoma of the anal canal: a review of the aetiology, presentation, staging, prognosis and methods available for treatment. Sex Health. 2012;9:593\u2013609.","journal-title":"Sex Health"},{"key":"758_CR27","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.amjsurg.2011.01.015","volume":"201","author":"E G","year":"2011","unstructured":"G E, Foo M, Harrow S, McGregor G, Hay J. Outcomes of salvage surgery for epidermoid carcinoma of the anus following failed combined modality treatment. Am J Surg. 2011;201:628\u201333.","journal-title":"Am J Surg"},{"key":"758_CR28","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ijrobp.2005.05.047","volume":"63","author":"O Chapet","year":"2005","unstructured":"Chapet O, Gerard JP, Riche B, Alessio A, Mornex F, Romestaing P. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys. 2005;63:1316\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"758_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1055\/s-0031-1286002","volume":"24","author":"JL Poggio","year":"2011","unstructured":"Poggio JL. Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal. Clin Colon Rect Surg. 2011;24:177\u201392.","journal-title":"Clin Colon Rect Surg"},{"issue":"17","key":"758_CR30","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1200\/JCO.2013.52.3464","volume":"32","author":"E Serup-Hansen","year":"2014","unstructured":"Serup-Hansen E, Linnemann D, Skovrider-Ruminski W, H\u00f8gdall E, Geertsen PF, Havsteen H. Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American joint committee on cancer stages I to III carcinoma of the anal canal. J Clin Oncol. 2014;32(17):1812.","journal-title":"J Clin Oncol"},{"key":"758_CR31","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.2217\/fon.15.136","volume":"11","author":"J Charlton","year":"2015","unstructured":"Charlton J, Pavasovic V, Pritchard-Jones K. Biomarkers to detect Wilms tumors in pediatric patients: where are we now? Future Oncol. 2015;11:2221\u201334.","journal-title":"Future Oncol"},{"key":"758_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.tig.2015.02.001","volume":"31","author":"A Sidow","year":"2015","unstructured":"Sidow A, Spies N. Concepts in solid tumor evolution. Trends Genet. 2015;31:208\u201314.","journal-title":"Trends Genet"},{"key":"758_CR33","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nrg2193","volume":"8","author":"JM Chen","year":"2007","unstructured":"Chen JM, Cooper DN, Chuzhanova N, F\u00e9rec C, Patrinos GP. Gene conversion: mechanisms, evolution and human disease. Nat Rev Genet. 2007;8:762\u201375.","journal-title":"Nat Rev Genet"},{"key":"758_CR34","first-page":"12","volume":"6","author":"S Haupt","year":"2016","unstructured":"Haupt S, Raghu D, Haupt Y. Mutant p53 drives cancer by subverting multiple tumor suppression pathways. Front Oncol. 2016;6:12.","journal-title":"Front Oncol"},{"key":"758_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/carcin\/bgp281","volume":"31","author":"S Boulenouar","year":"2010","unstructured":"Boulenouar S, Weyn C, Van Noppen M, Moussa Ali M, Favre M, Delvenne PO, Bex F, No\u00ebl A, Englert Y, Fontaine V. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells. Carcinogenesis. 2010;31:473\u201380.","journal-title":"Carcinogenesis"},{"key":"758_CR36","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1158\/1078-0432.CCR-07-1402","volume":"14","author":"W WH","year":"2008","unstructured":"WH W, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2008;14:366\u20139.","journal-title":"Clin Cancer Res"},{"key":"758_CR37","doi-asserted-by":"crossref","unstructured":"Williams AB, Schumacher B. p53 in the DNA-Damage-Repair Process. Cold Spring Harb Perspect Med. 2016;6","DOI":"10.1101\/cshperspect.a026070"},{"key":"758_CR38","first-page":"6489","volume":"9","author":"AS Allal","year":"2003","unstructured":"Allal AS, Waelchli L, Prognostic BMA. Value of apoptosis-regulating protein expression in anal squamous cell carcinoma. Clin Cancer Res. 2003;9:6489\u201396.","journal-title":"Clin Cancer Res"},{"key":"758_CR39","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1226::AID-CNCR3>3.0.CO;2-B","volume":"85","author":"SR Bonin","year":"1999","unstructured":"Bonin SR, Pajak TF, Russell AH, Coia LR, Paris KJ, Flam MS, Sauter ER. Overexpression Of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation therapy oncology group. Cancer. 1999;85:1226\u201333.","journal-title":"Cancer"},{"key":"758_CR40","first-page":"47","volume":"18","author":"M Indinnimeo","year":"1999","unstructured":"Indinnimeo M, Cicchini C, Stazi A, Giarnieri E, French D, Limiti MR, Ghini C, Vecchione A. Human Papillomavirus infection and p53 nuclear overexpression in anal canal carcinoma. J Exp Clin Cancer Res. 1999;18:47\u201352.","journal-title":"J Exp Clin Cancer Res"},{"key":"758_CR41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000227590","volume":"53","author":"G Tanum","year":"1996","unstructured":"Tanum G, Holm R. Anal carcinoma: a clinical approach to p53 and RB gene proteins. Oncologia. 1996;53:369\u201373.","journal-title":"Oncologia"},{"key":"758_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0360-3016(99)00188-1","volume":"45","author":"CS Wong","year":"1999","unstructured":"Wong CS, Tsao MS, Sharma V, Chapman WB, Pintilie M, Cummings BJ. Prognostic Role of p53 protein expression in epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 1999;45:309\u201314.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"758_CR43","first-page":"4","volume":"4","author":"EM Burd","year":"2016","unstructured":"Burd EM, Dean CL. Human Papillomavirus. Microbiol Spectr. 2016;4:4.","journal-title":"Microbiol Spectr"},{"key":"758_CR44","doi-asserted-by":"publisher","first-page":"e1288331","DOI":"10.1080\/2162402X.2017.1288331","volume":"6","author":"P Balermpas","year":"2017","unstructured":"Balermpas P, Martin D, Wieland U, Rave-Fr\u00e4nk M, Strebhardt K, R\u00f6del C, Fokas E, R\u00f6del F. Human papilloma virus load and PD-1\/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: rationale for immunotherapy. Oncoimmunology. 2017;6:e1288331.","journal-title":"Oncoimmunology"},{"key":"758_CR45","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3389\/fimmu.2017.01225","volume":"8","author":"D Martin","year":"2017","unstructured":"Martin D, R\u00f6del F, Winkelmann R, Balermpas P, R\u00f6del C, Fokas E. Peripheral leukocytosis is inversely correlated with Intratumoral CD8+ T-cell infiltration and associated with worse outcome after Chemoradiotherapy in anal cancer. Front Immunol. 2017;8:1225.","journal-title":"Front Immunol"},{"key":"758_CR46","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/bjc.2015.448","volume":"114","author":"DC Gilbert","year":"2016","unstructured":"Gilbert DC, Serup-Hansen E, Linnemann D, H\u00f8gdall E, Bailey C, Summers J, Havsteen H, Thomas GJ. Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer. Br J Cancer. 2016;114:134\u20137.","journal-title":"Br J Cancer"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-018-0758-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T19:22:29Z","timestamp":1550690549000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-018-0758-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,21]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["758"],"URL":"https:\/\/doi.org\/10.1186\/s12876-018-0758-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,21]]},"assertion":[{"value":"17 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was granted ethical approval by the Hospital Ophir Loyola Committee (HOL 72710\/12). A Free and Informed Consent Form was read and signed by patients who participated in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"30"}}